ReportGem ReportGem 中文

GLOBAL RESEARCH ARCHIVE

Natura Cosmeticos SA: 1Q26 – Brazil soft, Avon struggles, heavy charges ahead of G&A savings

Published: 2026-05-12Institution: BofA Global ResearchCompany / ticker: NATU3m.BAPages: 12Original language: 英语Evidence page: 1

Research evidence excerpt

Natura Cosmeticos SA: 1Q26 – Brazil soft, Avon struggles, heavy charges ahead of G&A savings

Accessible version

Natura Cosmeticos SA

1Q26 – Brazil soft, Avon struggles, heavy

charges ahead of G&A savings

Reiterate Rating: BUY | PO: 14.00 BRL | Price: 10.50 BRL

Revenue -7.7%, EBITDA -47%, charges & FX drive loss 11 May 2026

NATU reported an unexpected net loss of R$0.32/share vs consensus EPS of R$0.02, on Equity

weaker margins and FX losses. Net revenue fell 3.7% ex FX, on soft demand in Brazil

(revenue -5.5%), and a challenging Wave 2 rollout in Argentina (Hispanic -1.1% ex FX).

Operating deleverage and R$221mn in severance and other expenses drove a 46.8% Robert E. Ford Aguilar, CFA Research Analyst

EBITDA contraction. Ex charges, EBITDA declined 27.3% (margin -322bp). FCF of - BofAS

R$430mn reflected operating weakness, severance and Avon litigation settlement costs. +1robert.e.ford@bofa.com646 855 5439

Challenging Brazil, Avon continues to struggle MelissaResearchByun,AnalystCFA

Brazil was hit by soft Natura sales (-3.0%), particularly in the Northeast, and ongoing BofAS+1 646 855 3177

weakness at Avon (Beauty -13.8%, H&S -10.8%). Natura sellout growth reportedly melissa.byun@bofa.com

outperformed the market. Brazil’s average consultant base contracted 4.2% y/y, despite Gustavo Fratini >>

efforts to incentivize frequency and improve commissions, reflecting some migration to ResearchMerrill LynchAnalyst(Brazil)

digital channels (+23.6%, or 9.0% of revenue). Promotional activities (gross margin - +55 11 2188 4541

gustavo.fratini@bofa.com

140bp y/y), operating deleverage, health costs and prior-year tax credits drove a 30%

Wellington Santana >>

EBITDA contraction and 581bp margin decline ex 1x to 16.6% (reported EBITDA -36.2%). Research Analyst

Merrill Lynch (Brazil)

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer